XDR-TB in South Africa: Theory and practice [3]

PLoS Medicine

Volumn 4, Issue 4, 2007, Pages 770-771

  Andrews, Jason ^a   Basu, Sanjay ^a   Scales, David ^a   Maru, Duncan Smith Rohrberg ^a   Subbaraman, Ramnath ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; CAPREOMYCIN; MOXIFLOXACIN; TUBERCULOSTATIC AGENT;

CAUSE OF DEATH; CLINICAL PRACTICE; GOVERNMENT; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; LETTER; MEDICAL CARE; PATIENT CARE; SOUTH AFRICA; THEORETICAL STUDY; THORAX SURGERY; TUBERCULOSIS; METHODOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; NOTE; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; STANDARD;

ANTITUBERCULAR AGENTS; HUMANS; PATIENT ISOLATION; PLANNING TECHNIQUES; PRACTICE GUIDELINES AS TOPIC; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 34247506764     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040163     Document Type: Letter

References (5)

1. Singh JA, Upshur R, Padayatchi N (2007) XDR-TB in South Africa: No time for denial or complacency. PLoS Med 4: e50. doi:10.1371/journal.pmed.0040050
2. New York City Tuberculosis Working Group (1992) Developing a system for tuberculosis prevention and care in New York City. New York: United Hospital Fund.
3. Gasner MR, Maw KL, Feldman GE, Fujiwara PI, Frieden TR (1999) The use of legal action in New York City to ensure treatment of tuberculosis. New Engl J Med 340: 359-366.
4. Nullis C (2006 October 25) South Africa to spend $1.9B on World Cup. The Associated Press. Available: http://www.washingtonpost.com/wp-dyn/ content/article/2006/10/25/AR2006102501178.html. Accessed 16 March 2007.
5. Leimane V (2006) MDR-TB and XDR-TB: Management and treatment outcomes in Latvia [presentation]. 37th Union World Conference on Lung Health; 31 October - 4 November 2006; Paris, France.